The Global Radiation Therapy Market is Expected to Reach US$10.11 Billion in 2024, Witnessing Growth at a CAGR of 3.38%, Over the Period 2020-2024.
01 Jul 2022
Radiation Therapy
DUBLIN, July 1, 2022 /PRNewswire/ -- The "Global Radiation Therapy Market with Focus on LINAC: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has been added to
ResearchAndMarkets.com's offering.
The global radiation therapy market is expected to reach US$12.44 billion in 2026, witnessing growth at a CAGR of 6.75%, over the period 2022-2026. Factors such as surging incidence of cancer cases, rising healthcare expenditure, upsurge in economic growth, growing aging population, and expanding urbanization are expected to drive the market.
The growth of the market would be challenged by severe side effects of the therapy and stringent regulations and barriers to implementation. A few notable trends may include increasing public awareness, rising preference for noninvasive procedures, and advancements in technology.
The fastest-growing regional market in North America due to continuous inclination to the usage of novel technologies, rising disposable income and healthcare expenditure in the region, and rising awareness about procedures and sophisticated diagnostic techniques. Europe represents the second largest radiation therapy market and is already well-penetrated at developed market levels.
Key Topics Covered:
2. Impact of COVID-19
4. Global External & Internal Beam Radiation Therapy Market
4.1 Global External Beam Radiation Therapy Market
4.1.1 Global External Beam Radiation Therapy Market Forecast by Value
4.2 Global External Beam Radiation Therapy Market by Type
4.3 Global External Beam Radiation Therapy Market by Devices
4.3.1 Global LINAC Market Forecast by Value
4.3.2 Global LINAC Market Growth Potential
4.4 Global Internal Beam Radiation Therapy Market
4.4.1 Global Internal Beam Radiation Therapy Market Forecast by Value
5. Regional Market Analysis
5.1 North America
5.2 Europe
5.3 Asia Pacific
5.4 Latin America
5.5 Middle East & Africa
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Healthcare Expenditure
6.1.2 Surging Incidence of Cancer Cases
6.1.3 Expanding Urbanization
6.1.4 Growing Aging Population
6.1.5 Upsurge in Economic Growth
6.1.6 Adoption of Unhealthy Lifestyle
6.2 Key Trends and Developments
6.2.1 Shortage of Radiation Treatment Capacity
6.2.2 Advancements in Technology
6.2.3 Increasing Public Awareness
6.2.4 Rising Preference towards Non Invasive Procedures
6.2.5 Emergence of Artificial Intelligence
6.2.6 Surface-guided Radiotherapy (SGRT)
6.3 Challenges
6.3.1 Severe Side Effects of Therapy
6.3.2 Stringent Regulations
6.3.3 Barriers to Implementation
7. Competitive Landscape
7.1 Global Market
7.1.1 Revenue Comparison of Key Players
7.1.2 Market Capitalization Comparison of Key Players
7.1.3 R&D Comparison of Key Players
7.1.4 Global Radiation Therapy Installed Base Share by Company
7.1.5 Global LINAC Market Share by Company
7.1.6 Global LINAC New Sockets Share by Company
7.1.7 Global LINAC New Orders Share by Company
7.1.8 Global LINAC Installed Base Share by Company
7.2 North America
7.2.1 North America Radiation Therapy Market Share by Company
7.2.2 North America New LINAC Orders Share by Company
7.3 EMEA
7.3.1 EMEA Radiation Therapy Market Share by Company
7.3.2 EMEA New LINAC Orders Share by Company
7.4 Asia Pacific
7.4.1 Asia Pacific Radiation Therapy Market Share by Company
7.4.2 Asia Pacific New LINAC Orders Share by Company
7.4.3 China New LINAC Orders Share by Company
For more information about this report visit https://www.researchandmarkets.com/r/q6y6ij
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.